• 21st Century Cures Act (P.L. 114-255) implementation and oversight; SUPPORT for Patients and Communities Act (P.L. 115-271) implementation and oversight; the Reducing Unnecessary Senior Hospitalization Act (HR 6502, 115th); The Analyzing and Leveraging Existing Rx Transactions Act (HR 1845); The Overdose Prevention and Patient Safety Act (HR 2062); the Protecting Jessica Grubbs Legacy Act (S. 1012); The Mental Health Telemedicine Expansion Act (HR 1301); the Shop Rx Act (HR 3408); The Real-Time Beneficiary Drug Cost Bill (HR 3415); issues related to patient access to data; issues related to pharmacy real-time benefit transactions; issues related to Medicare coverage of telehealth services; issues relating to increased access to treatment for opioid misuse and abuse; issues relating to increased use of technology to combat opioid epidemic.

Duration: January 1, 2008 to September 30, 2019

General Issues: Health Issues

Spending: about $1,404,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), House of Representatives, Senate, Health & Human Services, Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), White House Office